Literature DB >> 21629333

The role of mTOR inhibitors in renal diseases.

J C Rodríguez Pérez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21629333     DOI： 10.3265/Nefrologia.pre2011.Apr.10947

Source DB:  PubMed          Journal:  Nefrologia        ISSN： 0211-6995            Impact factor:   2.033


× No keyword cloud information.
  2 in total

1.  Microparticles as Potential Mediators of High Glucose-Induced Renal Cell Injury.

Authors:  Sreenithya Ravindran; Mazhar Pasha; Abdelali Agouni; Shankar Munusamy
Journal:  Biomolecules       Date:  2019-08-06

2.  Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury.

Authors:  Lingling Wu; Zhe Feng; Shaoyuan Cui; Kai Hou; Li Tang; Jianhui Zhou; Guangyan Cai; Yuansheng Xie; Quan Hong; Bo Fu; Xiangmei Chen
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.